The Pancreas-Biliary Center immediately assigns professional coordinators to outpatients or pancreas-biliary patients visiting the ER due to severe pain to test quickly and proceed with hospitalization. The medical team of the Pancreas-Biliary Center, which is organically linked with the Gastroenterology, Radiology, Oncology and Hematology, Gastroenteric Pancreatic Surgery departments, gives immediate diagnosis and determines the direction of treatment depending on the patient’s condition and causative disease.

Cholelithiasis is a representative benign pancreas-biliary disease wherein stones are generated in the bile duct or gallbladder and is treated with oral·percutaneous endoscopic treatment, laparoscopic·robotic cholecystectomy, and open cholecystectomy. The Pancreas-Biliary Center has recorded a success rate of 90.3% in the endoscopic treatment of common bile duct gallstones only with oral routes, and percutaneous route treatments have all been successful for patients for which oral route treatments have failed. Moreover, about 1,100 cholecystotomies are performed every year, which is the second highest in Korea and the highest in the Southern Gyeonggi region.

Early diagnosis is difficult for pancreatic cancer, gallbladder cancer, and bile duct cancer, which are malignant pancreas-biliary diseases that do not show specific symptoms until they have significantly progressed, and there are many cases wherein radical operation is impossible upon diagnosis because major surrounding organs are invaded. Early diagnosis, proper surgical treatment, and anticancer drug treatment are very important to increase the survival rate of patients. The Pancreas-Biliary Center performs about 80 cancer surgeries including pancreaticoduodenectomy, and various methods including anticancer drug treatment, radiation treatment, conservative treatment, etc. are combined to select other treatments for patients for which surgery is difficult considering the extent of cancer, location, stage, age, and health condition of the patient.